Cardiovascular Systems, Inc. provided guidance for the fiscal year ending June 30, 2022. For the period, the company expects revenue to be between $235 million to $245 million and Net loss in a range of 15% to 18% of revenues.
Cardiovascular Systems, Inc.
Equities
CSII
US1416191062
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |